Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Driving the next generation of endocrinology care. See our social community guidelines: https://crinetics.com/social-media-community-guidelines/

We are a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Driven by the belief that no one should be defined by their disease, we’re transforming endocrine care to significantly improve the lives of patients, caregivers, and loved ones. As the premier, endocrine-rooted pharmaceutical

company, we’re shaping the future of treatment, empowering individuals to live beyond their condition, and thrive. Learn more at www.crinetics.com.

Today we announced that our treatment for adults with acromegaly has received approval by the European Commission. This ...
04/27/2026

Today we announced that our treatment for adults with acromegaly has received approval by the European Commission. This marks another step forward in expanding access to treatment for patients with acromegaly in Europe. Read more: https://bit.ly/48nj8B9

04/24/2026

Hormones play a role in nearly every system in the body, and when they’re out of balance, the effects can show up in unexpected ways. This World Hormone Day, Crinetics’ Bob Cuddihy, SVP of Medical Affairs, highlights the role of the endocrine system and common signs of imbalance. Watch to learn more:

At  , we’re contributing to the scientific exchange shaping endocrine care. Join us for an oral presentation tomorrow at...
04/23/2026

At , we’re contributing to the scientific exchange shaping endocrine care. Join us for an oral presentation tomorrow at 9:00am to explore thyroid management considerations in patients with acromegaly.

🗓 April 24, 2026
⏰ 9:00 – 9:15 AM PT
📍 Room 116

04/22/2026

We’re looking forward to participating at and contributing to the ongoing dialogue in endocrine care. We’ll be sharing two oral presentations at this year’s event. See below for session details and timing.

04/15/2026

Our culture is powered by people, and more than a few four-legged coworkers 🐾 From virtual dog walls to dog-friendly offices, we love celebrating what makes our teams feel at home. Meet a few of our four-legged coworkers ⬇️

Learn more about our culture: https://bit.ly/3BmigiR

04/13/2026

Crinetics was built on the conviction that patients with underserved endocrine diseases deserve better. Crinetics cofounders Scott Struthers and Stephen Betz recently joined to share what drove them to build a different kind of biotech company. Watch the full interview: https://www.youtube.com/watch?v=piyZ0_mxwDg

04/10/2026

Watch Crinetics CEO and cofounder Scott Struthers sit down with leading patient advocate Tony Alston to discuss the everyday reality of living with acromegaly: https://www.youtube.com/watch?v=O506FJkzMwI

We recently announced the submission of a Marketing Authorization Application for our proposed acromegaly treatment in B...
04/08/2026

We recently announced the submission of a Marketing Authorization Application for our proposed acromegaly treatment in Brazil.
Read more about this filing and our ongoing work in endocrinology: https://bit.ly/47OLunF

For people living with Cushing’s, the path to answers isn’t always straightforward. Symptoms can vary, mental and cognit...
04/08/2026

For people living with Cushing’s, the path to answers isn’t always straightforward. Symptoms can vary, mental and cognitive effects are often common, and even advanced imaging may not always reveal the cause. This Cushing’s Awareness Day, we’re raising awareness of the challenges patients may face and why continued progress in endocrine care matters.

We’re also proud to acknowledge the work of the Cushing’s Support & Research Foundation (CSRF), whose commitment to patient advocacy, education, and community-building helps ensure that no one navigates this journey alone.

By elevating awareness and supporting patient communities, we can help drive more informed care and more connected experiences for those affected by endocrine diseases.

We’re proud to share that Isabel Kalofonos, Chief Commercial Officer at Crinetics, has been named a 2026 MM+M Pinnacle A...
04/02/2026

We’re proud to share that Isabel Kalofonos, Chief Commercial Officer at Crinetics, has been named a 2026 MM+M Pinnacle Awards honoree. This recognition reflects her leadership in advancing a bold vision for the future of endocrine diseases that’s grounded in innovation, global impact, and an unwavering commitment to patients. It also honors her ability to lead with clarity and purpose in moments that demand resilience from our industry. Congratulations, Isabel!

03/26/2026

In celebration of National Science Day, we asked our team what science means to them. 🔬

At Crinetics, the passion and curiosity of our scientists drive the discoveries that aim to improve the lives of people living with endocrine diseases.

Interested in joining our team? We’re hiring:
• VP, Clinical Endocrinology
• VP, Drug Safety/ Pharmacovigilance

In honor of the internet’s favorite trend, we asked our office dogs to describe themselves on LinkedIn. Swipe to see wha...
03/17/2026

In honor of the internet’s favorite trend, we asked our office dogs to describe themselves on LinkedIn. Swipe to see what they said ➡️

Think you’re a fit for our pack? We’re hiring: https://crinetics.com/careers/

Address

6055 Lusk Boulevard
San Diego, CA
92121

Alerts

Be the first to know and let us send you an email when Crinetics Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Crinetics Pharmaceuticals:

Featured

Share